Molecular components underlying nongenomic thyroid hormone signaling in embryonic zebrafish neurons
© Yonkers and Ribera; licensee BioMed Central Ltd. 2009
Received: 25 February 2009
Accepted: 08 June 2009
Published: 08 June 2009
Neurodevelopment requires thyroid hormone, yet the mechanisms and targets of thyroid hormone action during embryonic stages remain ill-defined. We previously showed that the thyroid hormone thyroxine (T4) rapidly increases voltage-gated sodium current in zebrafish Rohon-Beard cells (RBs), a primary sensory neuron subtype present during embryonic development. Here, we determined essential components of the rapid T4 signaling pathway by identifying the involved intracellular messengers, the targeted sodium channel isotype, and the spatial and temporal expression pattern of the nongenomic αVβ3 integrin T4 receptor.
We first tested which signaling pathways mediate T4's rapid modulation of sodium current (INa) by perturbing specific pathways associated with nongenomic thyroid hormone signaling. We found that pharmacological blockade of protein phosphatase 1 and the mitogen-activated protein kinase p38 isoform decreased and increased tonic sodium current amplitudes, respectively, and blockade of either occluded rapid responses to acute T4 application. We next tested for the ion channel target of rapid T4 signaling via morpholino knock-down of specific sodium channel isotypes. We found that selective knock-down of the sodium channel α-subunit Nav1.6a, but not Nav1.1la, occluded T4's acute effects. We also determined the spatial and temporal distribution of a nongenomic T4 receptor, integrin αVβ3. At 24 hours post fertilization (hpf), immunofluorescent assays showed no specific integrin αVβ3 immunoreactivity in wild-type zebrafish embryos. However, by 48 hpf, embryos expressed integrin αVβ3 in RBs and primary motoneurons. Consistent with this temporal expression, T4 modulated RB INa at 48 but not 24 hpf. We next tested whether T4 rapidly modulated INa of caudal primary motoneurons, which express the receptor (αVβ3) and target (Nav1.6a) of rapid T4 signaling. In response to T4, caudal primary motoneurons rapidly increased sodium current peak amplitude 1.3-fold.
T4's nongenomic regulation of sodium current occurs in different neuronal subtypes, requires the activity of specific phosphorylation pathways, and requires both integrin αVβ3 and Nav1.6a. Our in vivo analyses identify molecules required for T4's rapid regulation of voltage-gated sodium current.
Although thyroid hormone deficiency results in severe neurodevelopmental deficits , the underlying mechanisms remain unclear. The traditional mechanism for thyroid hormone action involves conversion of secreted thyroxine (T4) to triiodothyronine (T3) by deiodination at the cellular level by target tissues. T3 then binds to intracellular nuclear thyroid hormone receptors to modulate transcription over a time course of hours to days [2, 3]. However, deletion of nuclear thyroid hormone receptors have little effect on development , suggesting that either unliganded thyroid hormone nuclear receptors mediate the consequences of hypothyroidism  or non-nuclear thyroid hormone receptors remain functional.
Recent studies have shown that exogenously applied T3 and T4 can act through extranuclear plasma membrane receptors on a timescale of minutes , providing a nongenomic mechanism for thyroid hormone signaling apart from traditional nuclear signaling. Bergh et al.  showed that the integrin dimer αVβ3 acts in vivo as a nongenomic thyroid hormone receptor in the chick chorioallantoic membrane and that T4-αVβ3 binding regulates angiogenesis. In addition, they found that αVβ3 displayed a higher binding affinity for T4 over T3. The increased specificity for T4 supports the view that T4 acts as more than a prohormone to T3.
Integrins are present during nervous system development  and regulate neuronal migration  and apoptosis . We previously reported that blockade of integrin αVβ3 reduced voltage-gated sodium current in Rohon-Beard primary sensory neurons (RBs) . Here, we focus on the intracellular pathways that translate T4-αVβ3 signaling into modulation of sodium current (INa). Davis and colleagues [7, 12] demonstrated that T4 binding to integrin αVβ3 activates the mitogen-activated protein kinase (MAPK) extracellular regulated kinase (ERK1/2) pathway. In addition, thyroid hormones can regulate other second messenger pathways, including the MAPK p38 isoform  and protein kinase C [14, 15]. The candidate intracellular messengers of rapid thyroid hormone signaling may regulate sodium channel function via phosphorylation.
One possible scenario is that the involved intracellular kinases and phosphatases directly regulate the phosphorylation state of a sodium channel. Consistent with this possibility, phosphorylation of voltage gated sodium channels by MAPK (p38) reduces INa amplitude by 50% . In the zebrafish embryo, MAPK (ERK1/2), MAPK (p38), and protein phosphatase (PP) subtypes PP1 and PP2A are all expressed in the spinal cord at 48 hours post-fertilization (hpf) , allowing for pharmacological assay of the effects of kinase and phosphatase inhibition on RB INa and embryonic T4 signaling.
Regardless of whether phosphorylation directly targets sodium channels, our data indicate that rapid T4 signaling regulates sodium channel function. In RBs, two different types of sodium channels, Nav1.1l and Nav1.6a, carry INa . The contribution of the two channel types to RB INa changes during development, with Nav1.6a channels accounting for a majority of RB current at 48 hpf. We previously found INa sensitivity to T4 at 48 hpf , raising the possibility that T4 rapidly regulates Nav1.6a channels. While Nav1.6a is the major contributor to RB INa, it is also widely expressed in the nervous system and is of critical importance to development . T4 regulation of Nav1.6a current would provide a mechanism for thyroid hormone to serve as an important developmental regulator of neural activity.
Here, we identify the signaling mechanisms and sodium channels underlying nongenomic T4 activity in embryonic zebrafish neurons. We also define the temporal and spatial expression pattern of the nongenomic T4 receptor, integrin αVβ3, in zebrafish embryos. Our results indicate that neuronal cell types expressing both αVβ3 and Nav1.6a sodium channels respond rapidly to T4 with an increase in INa amplitude.
Materials and methods
All experimental procedures were approved by the Animal Care and Use Committee of the Center for Comparative Medicine at the University of Colorado Denver – Anschutz Medical Campus.
Zebrafish (Danio rerio) adults were bred according to guidelines outlined in The Zebrafish Book . Embryos were incubated at 28.5°C in embryo medium (130 mM NaCl, 0.5 mM KCl, 0.02 mM Na2HPO4, 0.04 mM KH2PO4, 1.3 mM CaCl2, 1.0 mM MgSO4, 0.4 mM NaH2CO3) and staged according to external morphology .
Whole cell voltage clamp recordings were obtained from zebrafish spinal cord RBs as previously described [11, 18, 22]. Voltage clamp recordings from caudal primary motoneurons (CaPs) were obtained from the Tg(hb9:GFP) line (gift of Drs Michael Fox and Joshua Sanes, Harvard University, Cambridge, MA, USA) that express green fluorescent protein (GFP) in motoneurons . Tg(hb9:GFP) zebrafish were immobilized in Ringer solution (145 mM NaCl, 3 mM KCl, 1.8 mM CaCl2, and 10 mM HEPES, pH 7.2) containing 0.02% tricaine (Sigma St Louis, Missouri, USA) and glued laterally to glass coverslips. Glass dissecting needles sufficed for removal of skin and detachment of overlying muscle fibers. Muscle fibers and secondary motoneurons were removed by a suction pipette to expose primary motoneurons. Three properties identified CaPs: GFP expression, cell body size (approximately 10 μM diameter), and ventrally projecting axons . For initial experiments, we used a reduced extracellular sodium bath solution (30 mM NaCl, 97 mM N-methyl glucamine, 20 mM tetraethylammonium (TEA), 3 mM KCl, 2 mM CoCl2, and 10 mM HEPES) to reduce potential series resistance voltage errors arising from large INa amplitudes. However, some experimental manipulations (for example, knockdown of sodium channel α-subunits or phosphatase blockade) reduced INa amplitudes; in these cases, we used a normal 125 mM extracellular sodium concentration to increase INa amplitudes and the sensitivity of our measurements. Glass electrodes (2.0 to 3.5 MÙ) were filled with solution containing 10 mM NaCl, 135 mM CsCl, 10 mM EGTA, and 10 mM HEPES. We subtracted passive leak currents and capacitive transients from recordings of voltage-gated sodium using a P/8 protocol. Data were acquired using an Axopatch 200B amplifier (Axon Instruments, Foster City, California, USA) and analyzed with Clampfit8 (Axon Instruments) and Origin software (OriginLab, Northampton, Massachusetts, USA).
Results are presented as means ± standard errors. Statistical analysis was performed with Origin v7.0 software (OriginLab). Statistical comparisons of means were performed by one-way ANOVAs with Bonferroni corrections for multiple comparisons.
Hormone and drug application
T4 (3,3',5,5'-tetraiodo-L-thyronine (thyroxine); Sigma) was prepared as a 30 mM stock solution in dimethyl sulfoxide (DMSO) that was diluted to final concentrations in extracellular recording solution immediately before use. Vehicle (DMSO) control experiments indicated that the final concentration of DMSO (0.001%) had no effect on INa amplitudes; therefore, control and vehicle control data were pooled (Control/DMSO). Kinase and phosphatase inhibitors were applied to neurons in semi-intact preparations of the zebrafish embryo after obtaining control recordings prior to treatment. PD98059 (50 μM; Sigma), 1 μM SB203580 (Sigma), or okadaic acid (OA; 1 nM to 1 μM; Sigma) was applied for 1 hour at room temperature before obtaining post-treatment recordings. The drugs remained in the bath during post-treatment recording.
Whole mount embryos (24 to 48 hpf) were processed for immunocytochemistry as previously described . The primary antibody, mouse anti-human monoclonal LM609 (Millipore, Billerica, MA, USA), was diluted 1:100. Secondary antibody was applied overnight at 4°C (1:500; goat anti-mouse conjugated to Alexa 568; Invitrogen-Molecular Probes, Carlsbad, California, USA). Controls consisted of experiments done with LM609 that had been previously incubated with 50 μg/ml human αVβ3 (Millipore). In some experiments, the Tg(isl3:GFP) line (gift of Drs Andrew Pittman and Chi-Bin Chien, University of Utah) expressing GFP in RBs or the Tg(hb9:GFP) line expressing GFP in motoneurons were used. GFP expression was revealed using a rabbit anti-GFP antibody conjugated to Alexa 488 (1:400; Invitrogen). For analysis, embryos were mounted in a 1% low melting point agarose solution and imaged using a Zeiss Pascal Confocal Microscope using 10× or 40× objectives and separate 488 and 568 laser lines. Fluorescent images were collected digitally as z-stacks of 2 μm slices. Data are presented as projections of 20 to 25 slices.
Antisense oligonucleotide morpholinos (MOs) targeting sodium channels Nav1.6a (1.6 MO) and Nav1.1l (1.1 MO) were synthesized and prepared as previously described . Injection solutions contained the dye Fast Green (1%) to report efficient delivery of the MO to animal cells. For each Nav1 MO, control MOs were synthesized by introducing mismatches at five positions. Embryos that had either Nav1.6a or Nav1.1l sodium channel subunit knock-down were created by injection of 2 to 3 hpf wild-type embryos with solution containing 0.3 mM MO antisense oligonucleotide . All MOs have been used previously and tested by standard control experiments [18, 19, 26].
Embryos that had Fast Green within the animal cell 15 minutes post-injection were transferred to a petri dish containing embryo medium (130 mM NaCl, 0.5 mM KCl, 0.02 mM Na2HPO4, 0.04 mM KH2PO4, 1.3 mM CaCl2, 1.0 mM MgSO4, 0.4 mM NaH2CO3) and then raised at 28°C until 48 hpf. Embryos that were injected with the 1.6 MO or 1.1 MO and selected for recording are referred to as Nav1.6a or Nav1.1l morphants, respectively.
Blockade of either p38 MAPK or PP1 alters RB INa amplitude and occludes the rapid T4 effect
In other systems, rapid thyroid hormone signaling involves intracellular signaling kinase pathways such as MAPK (ERK1/2) and MAPK (p38) [7, 12, 13, 27–29]. To identify intracellular mediators of rapid T4 signaling in RBs, we used a pharmacological approach. We inhibited MAPK (ERK1/2) or MAPK (p38) signaling by using the blockers PD98059 or SB203580, respectively. In addition, because phosphatase effects oppose kinase action we used OA to block serine/threonine phosphatases. At low OA concentrations we blocked PP2A (1 to 20 nM OA) and at higher concentrations we blocked both PP2A and PP1 (1 μM OA). After incubation of spinal cord preparations in conditions of kinase or phosphatase blockade, we tested for effects of kinase and phosphatase inhibitors on INa amplitude, in the absence and presence of T4.
Whereas the PD98059 results suggest that the ERK1/2 pathway may partially mediate the rapid effects of T4, the data do not implicate ERK1/2 signaling in tonic regulation of the number of available sodium channels. In contrast, nongenomic T4 signaling regulates both the rapid response to T4 as well as the tonic levels of available sodium channels in RBs . Overall, the PD98059 results suggest minimal involvement of the ERK1/2 pathway in T4 regulation of RB INa.
We next tested the contribution of the MAPK (p38) pathway that mediates rapid thyroid hormone signaling triggered by T3  and regulates INa density . In contrast to blockade of the ERK1/2 pathway, pharmacological inhibition of the p38 pathway increased tonic INa amplitudes (in the absence of exogenous T4) 1.48-fold (2458 ± 134 pA; n = 14; P < 0.05, ANOVA) (Figure 1D). Moreover, following SB203580 treatment, T4 no longer produced a rapid increase in INa amplitude. In fact, after SB203580 treatment, T4 application led to a 22 ± 4% (n = 5) decrease in RB INa amplitude (Figure 2A, C). Overall, the effects of SB203580 support involvement of the p38 pathway in regulation of both the resting levels of available RB sodium channels as well as the rapid response of RB INa to T4.
The SB203580 results suggest that T4 acts rapidly on RBs by opposing ongoing MAPK p38 signaling either by inhibiting the kinase or by activating relevant serine/threonine phosphatases. Two serine/threonine phosphatases, PP2A and PP1, are both ubiquitously expressed in the zebrafish spinal cord at 48 hpf , a time when T4 rapidly regulates RB sodium current. To test for involvement of PP2A or PP1, we incubated zebrafish spinal cords with the serine/threonine phosphatase inhibitor OA prior to recording INa from RBs. At concentrations of 1 to 20 nM, OA specifically inhibits PP2A. However, 1 and 20 nM OA did not significantly alter INa peak amplitudes in the absence of T4 (1,761 ± 179 pA (n = 6) and 1,798 ± 283 pA (n = 11), respectively). In contrast, the IC50 for PP1 inhibition by OA is much higher (approximately 0.5 μM) . OA at 1 μM produced a drastic 90% reduction in resting RB INa peak amplitudes (169 ± 33 pA; n = 7; P < 0.00001, ANOVA; Figure 1D). Further, following 1 μM OA treatment, T4 no longer increased RB INa amplitude (-6 ± 4% change; n = 7; P = 0.98 versus no T4 added; Figure 2A, C). Both the tonic reduction in INa peak amplitude and the occlusion of rapid T4 effects under conditions of PP1 blockade support the view that PP1 activity modulates RB INa amplitudes.
Rapid T4 effects require sodium channel α-subunit Nav1.6a
We tested whether T4's rapid action on RB INa amplitude targeted a specific voltage-gated sodium channel isotype. RBs express two different sodium channel α-subunit genes, scn1.1l and scn8aa, which code for the voltage-gated sodium channel proteins Nav1.1l and Nav1.6a, respectively . Interestingly, the conductance carried by the mammalian homologue of Nav1.6a is significantly reduced by activation of MAPK p38 . We knocked down either Nav1.1l or Nav1.6a using MOs, as done previously for effective and selective elimination of specific Nav1 proteins in the zebrafish embryo [18, 19].
In contrast, in Nav1.1l morphant embryos, T4 application increased RB INa (63 ± 10%; P < 0.05 versus no hormone), suggesting that T4 does not require Nav1.1l channels to increase RB INa density. In Nav1.1l morphants, the increase in INa amplitude induced by T4 actually exceeded that produced in controls (63 ± 10% versus 45 ± 8%; P < 0.05), presumably because Nav1.6a channels carry the majority if not all of the remaining current . The effects of T4 on Nav1.6a and Nav1.1la morphants indicate that rapid T4 signaling targets Nav1.6a sodium channels.
Antagonists of nongenomic thyroid hormone signaling do not affect RB INa in Nav1.6a morphants
Antagonists of thyroid hormone (3,3',5,5'-tetraiodothyroacetic acid (tetrac)) or of the integrin αVβ3 block rapid T4 signaling in RBs . We next tested whether the effects of thyroid hormone antagonism or αVβ3 blockade targeted Nav1.6a-mediated current. We exposed Nav1.6a morphants to the thyroid hormone analog tetrac, or the αVβ3 function blocking antibody LM609. To more readily detect changes in RB INa amplitude in Nav1.6a morphants, we raised the extracellular sodium concentration to 125 mM to increase INa amplitudes. We previously showed that tetrac reduces RB INa amplitudes in wild-type embryos . However, in Nav1.6a morphants, tetrac did not significantly change RB INa amplitudes compared to Nav1.6a morphants unexposed to tetrac (Figure 3F). We had also previously demonstrated that LM609 reduced RB INa amplitudes by 46% in wild-type embryos . In contrast, in Nav1.6a morphants, LM609 injection did not significantly affect INa peak amplitudes compared to uninjected Nav1.6a morphants (Figure 3F). The lack of effect of either tetrac or LM609 in Nav1.6a morphants further supports that the rapid T4-integrin signaling pathway specifically targets Nav1.6a channels.
Developmental regulation of αVβ3 expression temporally restricts T4 signaling in RBs
Whether T4 induced increases in sodium current occur throughout development or if T4 signaling begins at a defined developmental stage is unknown. The above results combined with our previous study  indicate that in order to respond rapidly to T4 at 48 hpf, RBs require integrin αVβ3 and the Nav1.6a sodium channel α-subunit. We next determined whether αVβ3 is present and if RBs respond rapidly to T4 at earlier stages. We reasoned that absence of integrin αVβ3 would prevent T4 from rapidly modulating RB INa. Accordingly, we tested our prediction by determining the spatial and temporal αVβ3 expression pattern.
LM609 immunoreactive cells localized to the dorsal spinal cord where RBs reside. To identify LM609 immunoreactive cells as RBs, we used transgenic Tg(isl3:GFP) embryos. In this line, the isl3 promoter drives GFP expression in RBs (A Pittmann and Chi-Bin Chien, personal communication). In 48 hpf Tg(isl3:GFP) embryos (Figure 4D–F), LM609 immunoreactivity colocalized with GFP, revealing αVβ3 expression on RB bodies. This result is consistent with rapid αVβ3-dependent T4 signaling in 48 hpf RBs . In contrast, at 24 hpf, zebrafish embryos did not show specific LM609 immunolabeling in either the dorsal or ventral spinal cord (Figure 4B). These data indicate that αVβ3 dimers appear on RBs after 24 hpf.
T4 rapidly increases sodium current density in CaPs
At 48 hpf, the spinal cord contains three different types of primary motoneurons . One primary motoneuron, CaP, expresses Nav1.6a at 48 hpf [19, 33]. Because rapid T4 modulation of INa targets Nav1.6a, co-expression of Nav1.6a and integrin αVβ3 raised the possibility that CaPs might respond to T4 with a rapid increase in INa amplitude. To test this possibility, we applied 30 nM T4 to CaP motoneurons, identified in Tg(hb9:GFP) 48-hpf embryos by cell body size and ventrally projecting axons, while recording INa. In control CaP recordings, INa peak density decreased over 5 minutes by 7 ± 2%. However, CaP INa density significantly increased by 28 ± 8% (P < 0.005) after acute T4 application (Figure 6D–F). These results support our model that rapid regulation of INa density by T4 requires αVβ3 and targets Nav1.6a channels.
Our results identify messengers and targets of a rapid thyroid hormone signaling pathway that functions in the zebrafish embryonic nervous system. The T4 pathway rapidly induces increased sodium current amplitudes and requires the sodium channel isotype Nav1.6a even though neurons express several different sodium channel isotypes. Moreover, the results suggest that the phosphorylation state of an involved protein, perhaps even the targeted sodium channel isotype, determines sodium channel activity.
We propose a model in which the phosphorylation status of a particular protein or set of proteins regulates RB INa amplitude, and T4 rapidly alters the phosphorylation status of relevant protein(s). Further, the data suggest that serine/threonine phosphorylation and dephosphorylation reduce and increase, respectively, RB INa amplitude. To increase RB INa amplitude, T4 may rapidly activate PP1 and/or inhibit p38. Consistent with our findings, PP1 modulates INa amplitudes in rat striatal neurons , which express Nav1.6 . Schiffmann et al.  found that PP1 blockade reduced rat striatal INa amplitudes, similar to our results in zebrafish RBs.
Our data do not provide information about the identity of the phosphorylated protein(s). One possibility is that T4 binding to αVβ3 activates intracellular pathways that directly phosphorylate sodium channel α-subunits. In ND7/23 cells transfected with mammalian Nav1.6 sodium channels, activation of p38 produces a decrease in INa . Of particular relevance, biochemical analysis demonstrated that p38 activity regulated phosphorylation of a specific Nav1.6 serine, S553, revealing the Nav1.6 sodium channel as a direct p38 phosphorylation target . On this basis, the RB T4-αVβ3 pathway may modulate INa by regulating the phosphorylation state of the conserved serine residue in zebrafish Nav1.6a.
One result that the model does not fully account for, however, is the large reduction in RB INa amplitude produced by PP1 inhibition. We previously reported that either T4 or αVβ3 blockade reduced INa by only 50%, yet 1 μM OA reduced RB INa by nearly 90%. This discrepancy could be attributed to different degrees of PP1 inhibition by 1 μM OA versus T4/αVβ3 blockade. The large decrease in INa amplitude produced by 1 μM OA could also reflect phosphorylation effects triggered by non-T4-dependent mechanisms. For example, protein kinases C and A also have effects on Nav1.6 amplitude .
αVβ3 acts as a T4 receptor in the nervous system
The important developmental roles of integrins as cell surface adhesion proteins have been well studied . Less-well studied, however, is the potential role of integrins as receptors for hormones. Because neurons and glia  express αVβ3, nongenomic T4 signaling via αVβ3 may play an important role in nervous system development.
Here, we focused on integrin's role as a plasma membrane receptor for thyroid hormones that traditionally signal through nuclear receptors. We focused on the integrin dimer, αVβ3, a protein that is important for neuronal migration and axon extension [39–41], and is expressed on dorsal root ganglia [42, 43]. The fact that RGD (Asp-Gly-Arg) proteins block rapid T4 signaling mediated by αVβ3  suggests that the hormone interacts with the RGD recognition site . Davis et al. suggested that, in addition to αVβ3, seven other RGD integrin dimers may function as thyroid hormone receptors .
In addition to T4, the iodothyronine T3 binds to integrin αVβ3 and activates both ERK1/2 and phosphatidyl inositol 3-kinase . If T3 interacts with RB αVβ3 to activate ERK1/2 and phosphatidyl inositol 3-kinase, our data indicate that activation of these signaling pathways has no effect on RB INa amplitude. Although we found that T3 does not affect RB INa, previous studies show T3 can increase INa depending on cell type. For example, chronic T3 application increases INa in cultured rat hippocampal neurons , but not rat cortex in vitro. This result was attributed to increased nuclear thyroid hormone receptor expression in hippocampus versus cortex leading to differential genomic regulation of sodium channel expression. Additionally, T3 rapidly increases INa in cultured myocytes [47, 48] through mechanisms that involve rises in intracellular calcium  and protein kinase C . Altogether, both T4 and T3 nongenomic signaling result in a variety of downstream consequences due to the diversity of signaling mechanisms activated by plasma membrane thyroid hormone receptors.
Implications of rapid T4 targeting of Nav1.6a and importance to the nervous system
During intrauterine stages, the human embryo requires maternally provided thyroid hormone for normal development [49–51]. However, the specific roles and underlying mechanisms of thyroid hormone action during embryogenesis are poorly understood. Thyroid hormone signals nongenomically to regulate migration of neural cells in the embryonic nervous system . Our data indicate that thyroid hormone, acting rapidly via a plasma membrane receptor, shapes emerging properties of neuronal excitability. Specifically, thyroid hormone rapidly modulates neuronal sodium current by targeting the Nav1.6a subunit. The implications for mammals are substantial because the mammalian homologue, Nav1.6, shows widespread expression in both the central and peripheral nervous systems [53, 54] and is highly expressed during embryonic stages . Moreover, Nav1.6a plays important developmental roles for sensory neuron survival and motoneuron axon growth in zebrafish [19, 25]. Taken together, these findings indicate that modulation of Nav1.6 current during embryonic stages serves as a strategic way to regulate both structural and functional development of the nervous system.
In the context of our results, periods of thyroid hormone deprivation during development would decrease sodium current in neurons expressing both αVβ3 and Nav1.6, leading to reduced excitability. Conversely, an excess of thyroid hormone would increase sodium current and potentially induce pathological hyperexcitability, associated with seizures and developmental abnormalities. Interestingly, increased expression of Nav1.6 channels are associated with epileptogenesis in mouse hippocampal neurons through mechanisms of enhanced excitability , and acute increases in T4 have been reported to cause seizures in humans . Also of note, mice without the functional sodium channel gene SCN8A are somewhat resistant to seizures  and children with congenital hypothyroidism have a significantly reduced incidence of febrile convulsions . Whether thyroid hormone can acutely influence seizure activity through αVβ3-dependent regulation of Nav1.6 in mammals warrants further study. Altogether, T4 regulation of Nav1.6a current provides an important mechanism to influence neuronal activity and development.
We focused on rapid T4 signaling in the embryonic nervous system. However, αVβ3 and Nav1.6 are also present in the adult nervous system, raising the possibility that T4 acutely regulates sodium current in adults. During adult stages, Nav1.6 is the primary sodium channel isoform expressed at nodes of Ranvier . T4 induced modulation of Nav1.6 mediated current would alter INa at nodes of Ranvier and, therefore, regulate axonal conductance. The mechanism of thyroid hormone action on adult neurons is unclear, yet alterations in Nav1.6 current could result in deficits in sensory neuron axonal conductance and could account for states of hyper- or hypo-reflexia observed in hyper- or hypothyroid patients, respectively [60, 61]. Studies on T4-αVβ3's activation of angiogenesis and tumor cell proliferation also have clinical corollaries in adults as hypothyroid states reduce tumor cell proliferation in gliomas .
Our results delineate a pathway for rapid T4 signaling that is initiated by αVβ3 as a T4 receptor, transduced intracellularly by regulation of phosphorylation states, and targets the Nav1.6a sodium channel α-subunit. Our proposed pathway predicts that T4's rapid modulation of sodium current requires expression of both αVβ3 and Nav1.6a on the responding cell. Our data agree with the prediction in three ways. First, in RBs, T4 rapidly increased sodium current amplitudes at 48 but not 24 hpf, consistent with detection of αVβ3 at 48 but not 24 hpf. Second, upon knock-down of Nav1.6a protein, exogenously applied T4 no longer led to a rapid increase in RB INa amplitude. Third, another neuronal population, CaP, which expresses both αVβ3 and Nav1.6a, responded to T4 with a rapid increase in INa amplitude. Uncovering the signaling pathways and relevant proteins involved in nongenomic T4 signaling contributes to our understanding of how thyroid hormone regulates development and function of the nervous system.
caudal primary motoneuron
MAPK extracellular regulated kinase
green fluorescent protein
mitogen-activated protein kinase
voltage-gated sodium channel
MAPK p38 isoform
3,5,3',5'-tetraiodothyronine or thyroxine
The authors thank M Perales and C Veng for care of zebrafish, Dr AD Robertson for statistical advice, and Dr Kurt Beam and the Ribera lab for discussion. This work was supported by National Institute of Health F30NS059147 (MAY), R01NS038937 (ABR) and P30NS048154 (ABR).
- Hetzel BS: Iodine and neuropsychological development. J Nutr. 2000, 130: 493S-495S.PubMedGoogle Scholar
- Zhang J, Lazar MA: The mechanism of action of thyroid hormones. Annu Rev Physiol. 2000, 62: 439-466.View ArticlePubMedGoogle Scholar
- Yen PM: Physiological and molecular basis of thyroid hormone action. Physiol Rev. 2001, 81: 1097-1142.PubMedGoogle Scholar
- Gothe S, Wang Z, Ng L, Kindblom JM, Barros AC, Ohlsson C, Vennstrom B, Forrest D: Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev. 1999, 13: 1329-1341.PubMed CentralView ArticlePubMedGoogle Scholar
- Wondisford FE: Thyroid hormone action: insight from transgenic mouse models. J Investig Med. 2003, 51: 215-220.PubMedGoogle Scholar
- Davis PJ, Davis FB: Nongenomic actions of thyroid hormone. Thyroid. 6: 497-504.
- Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ: Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology. 2005, 146: 2864-2871.View ArticlePubMedGoogle Scholar
- Clegg DO, Wingerd KL, Hikita ST, Tolhurst EC: Integrins in the development, function and dysfunction of the nervous system. Front Biosci. 2003, 8: d723-750.View ArticlePubMedGoogle Scholar
- Anton ES, Kreidberg JA, Rakic P: Distinct functions of alpha3 and alpha(v) integrin receptors in neuronal migration and laminar organization of the cerebral cortex. Neuron. 1999, 22: 277-289.View ArticlePubMedGoogle Scholar
- Hisatomi T, Sakamoto T, Sonoda KH, Tsutsumi C, Qiao H, Enaida H, Yamanaka I, Kubota T, Ishibashi T, Kura S, Susin SA, Kroemer G: Clearance of apoptotic photoreceptors: elimination of apoptotic debris into the subretinal space and macrophage-mediated phagocytosis via phosphatidylserine receptor and integrin alphavbeta3. Am J Pathol. 2003, 162: 1869-1879.PubMed CentralView ArticlePubMedGoogle Scholar
- Yonkers MA, Ribera AB: Sensory neuron sodium current requires nongenomic actions of thyroid hormone during development. J Neurophysiol. 2008, 100: 2719-2725.PubMed CentralView ArticlePubMedGoogle Scholar
- Mousa SA, O'Connor LJ, Bergh JJ, Davis FB, Scanlan TS, Davis PJ: The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin. J Cardiovasc Pharmacol. 2005, 46: 356-360.View ArticlePubMedGoogle Scholar
- Irrcher I, Walkinshaw DR, Sheehan TE, Hood DA: Thyroid hormone (T3) rapidly activates p38 and AMPK in skeletal muscle in vivo. J Appl Physiol. 2008, 104: 178-185.View ArticlePubMedGoogle Scholar
- Lawrence WD, Schoenl M, Davis PJ: Stimulation in vitro of rabbit erythrocyte cytosol phospholipid-dependent protein kinase activity. A novel action of thyroid hormone. J Biol Chem. 1989, 264: 4766-4768.PubMedGoogle Scholar
- Incerpi S, Luly P, De Vito P, Farias RN: Short-term effects of thyroid hormones on the Na/H antiport in L-6 myoblasts: high molecular specificity for 3,3',5-triiodo-L-thyronine. Endocrinology. 1999, 140: 683-689.PubMedGoogle Scholar
- Wittmack EK, Rush AM, Hudmon A, Waxman SG, Dib-Hajj SD: Voltage-gated sodium channel Nav1.6 is modulated by p38 mitogen-activated protein kinase. J Neurosci. 2005, 25: 6621-6630.View ArticlePubMedGoogle Scholar
- Thisse B, Heyer V, Lux A, Alunni V, Degrave A, Seiliez I, Kirchner J, Parkhill JP, Thisse C: Spatial and temporal expression of the zebrafish genome by large-scale in situ hybridization screening. Methods Cell Biol. 2004, 77: 505-519.View ArticlePubMedGoogle Scholar
- Pineda RH, Heiser RA, Ribera AB: Developmental, molecular, and genetic dissection of INa in vivo in embryonic zebrafish sensory neurons. J Neurophysiol. 2005, 93: 3582-3593.View ArticlePubMedGoogle Scholar
- Pineda RH, Svoboda KR, Wright MA, Taylor AD, Novak AE, Gamse JT, Eisen JS, Ribera AB: Knockdown of Nav1.6a Na+ channels affects zebrafish motoneuron development. Development. 2006, 133: 3827-3836.View ArticlePubMedGoogle Scholar
- Westerfield M: The Zebrafish Book: a Guide for the Laboratory Use of Zebrafish (Brachydanio rerio). 1995, Eugene: University of Oregon PressGoogle Scholar
- Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF: Stages of embryonic development of the zebrafish. Dev Dyn. 1995, 203: 253-310.View ArticlePubMedGoogle Scholar
- Ribera AB, Nüsslein-Volhard C: Zebrafish touch-insensitive mutants reveal an essential role for the developmental regulation of sodium current. J Neurosci. 1998, 18: 9181-9191.PubMedGoogle Scholar
- Flanagan-Steet H, Fox MA, Meyer D, Sanes JR: Neuromuscular synapses can form in vivo by incorporation of initially aneural postsynaptic specializations. Development. 2005, 132: 4471-4481.View ArticlePubMedGoogle Scholar
- Myers PZ, Eisen JS, Westerfield M: Development and axonal outgrowth of identified motoneurons in the zebrafish. J Neurosci. 1986, 6: 2278-2289.PubMedGoogle Scholar
- Svoboda KR, Linares AE, Ribera AB: Activity regulates programmed cell death of zebrafish Rohon-Beard neurons. Development. 2001, 128: 3511-3520.PubMedGoogle Scholar
- Eisen JS, Smith JC: Controlling morpholino experiments: don't stop making antisense. Development. 2008, 135: 1735-1743.View ArticlePubMedGoogle Scholar
- Davis PJ, Davis FB, Cody V: Membrane receptors mediating thyroid hormone action. Trends Endocrinol Metab. 2005, 16: 429-435.View ArticlePubMedGoogle Scholar
- Davis PJ, Davis FB, Bergh JJ, Lin H-Y: Defining the roles of the cell surface receptor for thyroid hormone. Hot Thyroidol. 2006, [http://www.hotthyroidology.com/editorial_157.html]Google Scholar
- Davis PJ, Leonard JL, Davis FB: Mechanisms of nongenomic actions of thyroid hormone. Front Neuroendocrinol. 2008, 29: 211-218.View ArticlePubMedGoogle Scholar
- Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 1995, 270: 27489-27494.View ArticlePubMedGoogle Scholar
- Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA. 1995, 92: 7686-7689.PubMed CentralView ArticlePubMedGoogle Scholar
- Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemura D: Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun. 1989, 159: 871-877.View ArticlePubMedGoogle Scholar
- Novak AE, Taylor AD, Pineda RH, Lasda EL, Wright MA, Ribera AB: Embryonic and larval expression of zebrafish voltage-gated sodium channel alpha-subunit genes. Dev Dyn. 2006, 235: 1962-1973.View ArticlePubMedGoogle Scholar
- Cheresh DA, Spiro RC: Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem. 1987, 262: 17703-17711.PubMedGoogle Scholar
- Schiffmann SN, Desdouits F, Menu R, Greengard P, Vincent JD, Vanderhaeghen JJ, Girault JA: Modulation of the voltage-gated sodium current in rat striatal neurons by DARPP-32, an inhibitor of protein phosphatase. Eur J Neurosci. 1998, 10: 1312-1320.View ArticlePubMedGoogle Scholar
- Richardson PJ, Dixon AK, Lee K, Bell MI, Cox PJ, Williams R, Pinnock RD, Freeman TC: Correlating physiology with gene expression in striatal cholinergic neurones. J Neurochem. 2000, 74: 839-846.View ArticlePubMedGoogle Scholar
- Chen Y, Yu FH, Sharp EM, Beacham D, Scheuer T, Catterall WA: Functional properties and differential neuromodulation of Na(v)1.6 channels. Mol Cell Neurosci. 2008, 38: 607-615.PubMed CentralView ArticlePubMedGoogle Scholar
- Milner R: Microglial expression of alphavbeta3 and alphavbeta5 integrins is regulated by cytokines and the extracellular matrix: beta5 Integrin null microglia show no defects in adhesion or MMP-9 expression on vitronectin. Glia. 2009, 57: 714-723.View ArticlePubMedGoogle Scholar
- Tawil NJ, Wilson P, Carbonetto S: Expression and distribution of functional integrins in rat CNS glia. J Neurosci Res. 1994, 39: 436-447.View ArticlePubMedGoogle Scholar
- Yip PM, Zhao X, Montgomery AM, Siu CH: The Arg-Gly-Asp motif in the cell adhesion molecule L1 promotes neurite outgrowth via interaction with the alphavbeta3 integrin. Mol Biol Cell. 1998, 9: 277-290.PubMed CentralView ArticlePubMedGoogle Scholar
- Garcion E, Faissner A, ffrench-Constant C: Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration. Development. 2001, 128: 2485-2496.PubMedGoogle Scholar
- Pittier R, Sauthier F, Hubbell JA, Hall H: Neurite extension and in vitro myelination within three-dimensional modified fibrin matrices. J Neurobiol. 2005, 63: 1-14.View ArticlePubMedGoogle Scholar
- Hajj GN, Lopes MH, Mercadante AF, Veiga SS, da Silveira RB, Santos TG, Ribeiro KC, Juliano MA, Jacchieri SG, Zanata SM, Martins VR: Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins. J Cell Sci. 2007, 120: 1915-1926.View ArticlePubMedGoogle Scholar
- Cody V, Davis PJ, Davis FB: Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin. Steroids. 2007, 72: 165-170.View ArticlePubMedGoogle Scholar
- Lin HY, Sun M, Tang HY, Lin C, Luidens MK, Mousa SA, Incerpi S, Drusano GL, Davis FB, Davis PJ: L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Am J Physiol Cell Physiol. 2009, 296: C980-991.View ArticlePubMedGoogle Scholar
- Hoffmann G, Dietzel ID: Thyroid hormone regulates excitability in central neurons from postnatal rats. Neuroscience. 2004, 125: 369-379.View ArticlePubMedGoogle Scholar
- Huang CJ, Geller HM, Green WL, Craelius W: Acute effects of thyroid hormone analogs on sodium currents in neonatal rat myocytes. J Mol Cell Cardiol. 1999, 31: 881-893.View ArticlePubMedGoogle Scholar
- Wang YG, Dedkova EN, Fiening JP, Ojamaa K, Blatter LA, Lipsius SL: Acute exposure to thyroid hormone increases Na+ current and intracellular Ca2+ in cat atrial myocytes. J Physiol. 2003, 546: 491-499.PubMed CentralView ArticlePubMedGoogle Scholar
- Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, de Vijlder JJ: Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf). 2003, 59 (3): 282-288.View ArticlePubMedGoogle Scholar
- Pop VJ, Kuijpens JL, van Baar AL, Verkerk G, van Son MM, de Vijlder JJ, Vulsma T, Wiersinga WM, Drexhage HA, Vader HL: Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol. 1999, 50: 149-155.View ArticleGoogle Scholar
- Morreale de Escobar G, Obregon MJ, Escobar del Rey F: Role of thyroid hormone during early brain development. Eur J Endocrinol. 2004, 151 (Suppl 3): U25-37.View ArticlePubMedGoogle Scholar
- Farwell AP, Dubord-Tomasetti SA, Pietrzykowski AZ, Stachelek SJ, Leonard JL: Regulation of cerebellar neuronal migration and neurite outgrowth by thyroxine and 3,3',5'-triiodothyronine. Brain Res Dev Brain Res. 2005, 154: 121-135.View ArticlePubMedGoogle Scholar
- Caldwell JH, Schaller KL, Lasher RS, Peles E, Levinson SR: Sodium channel Na(v)1.6 is localized at nodes of ranvier, dendrites, and synapses. Proc Natl Acad Sci USA. 2000, 97: 5616-5620.PubMed CentralView ArticlePubMedGoogle Scholar
- Van Wart A, Matthews G: Impaired firing and cell-specific compensation in neurons lacking Nav1.6 sodium channels. J Neurosci. 2006, 26: 7172-7180.View ArticlePubMedGoogle Scholar
- Shah BS, Stevens EB, Pinnock RD, Dixon AK, Lee K: Developmental expression of the novel voltage-gated sodium channel auxiliary subunit beta3, in rat CNS. J Physiol. 2001, 534: 763-776.PubMed CentralView ArticlePubMedGoogle Scholar
- Blumenfeld H, Lampert A, Klein JP, Mission J, Chen MC, Rivera M, Dib-Hajj S, Brennan AR, Hains BC, Waxman SG: Role of hippocampal sodium channel Nav1.6 in kindling epileptogenesis. Epilepsia. 2009, 50: 44-55.PubMed CentralView ArticlePubMedGoogle Scholar
- Tsutaoka BT, Kim S, Santucci S: Seizure in a child after an acute ingestion of levothyroxine. Pediatr Emerg Care. 2005, 21: 857-859.View ArticlePubMedGoogle Scholar
- Martin MS, Tang B, Papale LA, Yu FH, Catterall WA, Escayg A: The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy. Hum Mol Genet. 2007, 16: 2892-2899.View ArticlePubMedGoogle Scholar
- Asami T, Sasagawa F, Kyo S, Asami K, Uchiyama M: Incidence of febrile convulsions in children with congenital hypothyroidism. Acta Paediatr. 1998, 87: 623-626.View ArticlePubMedGoogle Scholar
- Gross MA: Achilles-reflex timing in diagnosis of thyroid status. N Y State J Med. 1971, 71 (19): 2283-2291.PubMedGoogle Scholar
- Goulis DG, Tsimpiris N, Delaroudis S, Maltas B, Tzoiti M, Dagilas A, Avramides A: Stapedial reflex: a biological index found to be abnormal in clinical and subclinical hypothyroidism. Thyroid. 1998, 8: 583-587.View ArticlePubMedGoogle Scholar
- Hercbergs AA, Goyal LK, Suh JH, Lee S, Reddy CA, Cohen BH, Stevens GH, Reddy SK, Peereboom DM, Elson PJ, Gupta MK, Barnett GH: Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study. Anticancer Res. 2003, 23: 617-626.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.